Lepu Biopharma Co., Ltd.

This phase 2 trial is testing a treatment called cretostimogene grenadenorepvec, a modified virus designed to infect and destroy cancer cells, in 16 people with high-risk bladder cancer that has not responded to standard BCG therapy. The study aims to see if the treatment can mak…

This study tests an experimental drug called MRG006A in 343 adults with advanced solid tumors that have spread or cannot be removed. The drug is given through a vein. The main goals are to find the safest dose and see if the drug can shrink tumors. The trial is currently recruiti…